• Login
    Browsing Schizophrenia and Psychotic Disorders by Title 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Schizophrenia and Psychotic Disorders
    • Browsing Schizophrenia and Psychotic Disorders by Title
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Schizophrenia and Psychotic Disorders
    • Browsing Schizophrenia and Psychotic Disorders by Title
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browsing Schizophrenia and Psychotic Disorders by Title

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Sort by:

    Order:

    Results:

    Now showing items 44-63 of 86

    • title
    • issue date
    • submit date
    • xmlui.ArtifactBrowser.ConfigurableBrowse.sort_by.discipline
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis 

        External author(s) only (2019-07)
        Importance: Experimental and epidemiological studies implicate the cannabinoid 1 receptor (CB1R) in the pathophysiology of psychosis. However, whether CB1R levels are altered in the early stages of psychosis and whether ...
      • Thumbnail

        Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2) 

        Lennox, Belinda; Yeeles, Ksenija; Tomei, Giuliano; Pollard, Rebecca; Vincent, Sally-Anne; Shimazaki, Mio (2019-06)
        Background: Evidence is conflicting about a causal role of inflammation in psychosis and, specifically, regarding antibodies binding to neuronal membrane targets, especially N-methyl-D-aspartate receptors. NMDAR, LGI1 and ...
      • Thumbnail

        Is adjunctive CBT really effective for schizophrenia? 

        Reid, Katherine (2019-09)
        Although antipsychotic medication remains the mainstay of treatment for schizophrenia, medications alone are not always successful. Cognitive– behavioural therapy (CBT) is recommended as an adjunct to pharmacological ...
      • Thumbnail

        Is there a choice to make? A pilot study investigating attitudes towards treatment in an Early Intervention for Psychosis service 

        Cowdrey, Felicity A (2018-03)
        Purpose The purpose of this paper is to investigate health care professionals’ (HCPs) and service-users’ (SUs) attitudes towards different treatment options in an Early Intervention for Psychosis (EIP) service as well as ...
      • Thumbnail

        The journey of adolescent paranoia: A qualitative study with patients attending child and adolescent mental health services 

        Bird, Jessica C.; Freeman, Daniel; Waite, Felicity (2022-02)
        Objectives: Paranoia is most likely to emerge in adolescence. In adolescents with mental health disorders, the disruptive effect of paranoia on social relationships could worsen outcomes. However, little is known about ...
      • Thumbnail

        Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia 

        Mould, Arne; Al-Juffali, Noura; Tunbridge, Elizabeth (2021-12)
        The cognitive dysfunction experienced by patients with schizophrenia represents a major unmet clinical need. We believe that enhancing synaptic function and plasticity by targeting kalirin may provide a novel means to ...
      • Thumbnail

        Ketamine for Psychiatric Disorders 

        McShane, Rupert (2019-07)
        This new edition of The ECT Handbook comes six years after the publication of the 3rd edition. In the intervening period there have been no major changes in the practice of electroconvulsive therapy, but continuing research ...
      • Thumbnail

        Measuring Disturbance of the Endocannabinoid System in Psychosis A Systematic Review and Meta-analysis 

        Cipriani, Andrea; Lennox, Belinda; Godlewska, Beata R (2019-06)
        Importance: The endocannabinoid system (ECS) is a lipid-based endogenous signaling system. Its relevance to psychosis is through the association between cannabis use and the onset and course of illness and through the ...
      • Thumbnail

        Measuring reasoning in paranoia: Development of the Fast and Slow Thinking Questionnaire 

        Freeman, Daniel (2020-07)
        Paranoid thoughts are common across the psychosis continuum. It is well established that reasoning biases (conceived as an overreliance on fast thinking and lack of willingness and/or ability to engage in slow thinking) ...
      • Thumbnail

        Mental health professionals’ experiences of working with parents with psychosis and their families: a qualitative study 

        Johns, Louise (2021-04)
        Healthcare service users who are parents with psychosis form part of the caseload of most community mental health teams. Mental health professionals can experience uncertainty about how to work with and ask about the ...
      • Thumbnail

        Mindfulness and acceptance based therapies for psychosis. 

        Johns, Louise (2021-06)
        This chapter describes two approaches—person-based cognitive therapy (PBCT) and acceptance and commitment therapy (ACT)—that belong to the group of "third-wave" or contextual cognitive-behavioral therapies (CBTs). "Thirdwave" ...
      • Thumbnail

        Paranoia in patients attending child and adolescent mental health services 

        Bird, Jessica C.; Fergusson, Emma C.; Shearn, Christina; Teale, Ashley-Louise; Stratford, Hannah J.; James, Anthony; Waite, Felicity; Freeman, Daniel (2021-01)
        OBJECTIVE: Paranoia may be particularly prevalent during adolescence, building on the heightened social vulnerabilities at this age. Excessive mistrust may be corrosive for adolescent social relationships, especially in ...
      • Thumbnail

        Parenting behaviour and paranoia: a network analysis and results from the National Comorbidity Survey-Adolescents (NCS-A) 

        Waite, Felicity; Freeman, Daniel (2020-08)
        Method We examined cross-sectional associations of parenting and paranoia in an epidemiologically representative cohort of 10,148 adolescents (National Comorbidity Survey-Adolescents; NCS-A) and a second dataset of 1286 ...
      • Thumbnail

        Participatory design to create a VR therapy for psychosis 

        Lambe, Sinead; Waite, Felicity; Freeman, Daniel (2021-02)
        This paper describes how participatory design was employed in the design of an automated Virtual Reality (VR) psychological therapy (gameChange), putting people with lived experience of psychosis at the heart of the process. ...
      • Thumbnail

        A Phenomenological Exploration of the Voices Reported by Borderline Personality and Schizophrenia Patients 

        Barrera, Alvaro; Bajorek, Thomas; Dekker, Romanie; Lewis, A; Pearce, Steve (2021-06)
        Introduction: Over time, there have been different views regarding the verbal auditory hallucinations (VAHs) reported by borderline personality disorder (BPD) and schizophrenia patients. More recently, their similarity has ...
      • Thumbnail

        The place of free will and agency in psychiatric practice 

        Pearce, Steve (2020-01)
      • Thumbnail

        Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis 

        Broome, Matthew R. (2018-01-30)
        Preclinical models propose that the onset of psychosis is associated with hippocampal hyperactivity, thought to be driven by cortical GABAergic interneuron dysfunction and disinhibition of pyramidal neurons. Recent ...
      • Thumbnail

        Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT 

        Broome, Matthew R.; Freeman, Daniel; Johns, Louise; James, Anthony; Maughan, Daniel L (2021-01)
        Background: When psychosis emerges in young people there is a risk of poorer outcomes, and access to evidence-based treatments is paramount. The current evidence base is limited. Antipsychotic medications show only a small ...
      • Thumbnail

        The psychological journey of weight gain in psychosis 

        Waite, Felicity; Langman-Levy, Amy; Mulhall, Sophie; Lennox, Belinda; Freeman, Daniel (2022-02)
        Rapid weight gain is common with antipsychotic medication. Lost confidence, low mood and medication non-adherence often follow. Yet, the dynamic interactions between the physical and psychological consequences of weight ...
      • Thumbnail

        Psychological mechanisms connected to dissociation: Generating hypotheses using network analyses 

        Ehlers, Anke; Freeman, Daniel (2022-02)
        A large number of mechanisms, many relating to the processing of affect, have been proposed to cause dissociation. The aim of this study was to use network analyses to identify psychological processes most closely connected ...

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc
         

         

        Browse

        All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

        My Account

        Login

        Researcher Profiles

        Researchers

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc